Odyssey Health, Inc.
ODYY
$0.0081
-$0.0003-3.57%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -85.95% | -29.59% | -126.78% | -64.85% | -15.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -86.47% | -31.50% | -136.24% | -65.98% | -12.09% |
| Operating Income | 86.47% | 31.50% | 136.24% | 65.98% | 12.09% |
| Income Before Tax | -101.66% | -89.39% | -1,465.05% | 34.41% | 894.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.66% | -89.39% | -1,465.05% | 34.41% | 894.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.66% | -89.39% | -1,465.05% | 34.41% | 894.26% |
| EBIT | 86.47% | 31.50% | 136.24% | 65.98% | 12.09% |
| EBITDA | 86.50% | 31.48% | 136.29% | 65.95% | 12.08% |
| EPS Basic | -101.46% | -46.97% | -1,166.67% | 47.40% | 804.41% |
| Normalized Basic EPS | 85.23% | 51.25% | 115.00% | 70.10% | 23.48% |
| EPS Diluted | -101.79% | 0.00% | -1,132.04% | 50.00% | 676.47% |
| Normalized Diluted EPS | 81.69% | 51.25% | 115.00% | 70.10% | 38.26% |
| Average Basic Shares Outstanding | 13.85% | 29.27% | 22.96% | 24.80% | 12.46% |
| Average Diluted Shares Outstanding | -8.19% | 29.24% | 22.96% | 24.80% | 39.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |